Om Pharmaceutical Industries

Palghar, India Founded: 2004 • Age: 22 yrs
Manufactures and supplies active pharmaceutical ingredients and intermediates with FDA-approved facilities.

About Om Pharmaceutical Industries

Om Pharmaceutical Industries is a Healthcare company based in Palghar (India) founded in 2004. It manufactures and supplies active pharmaceutical ingredients and intermediates with FDA-approved facilities. It operates on a B2B model. Its Indian entity Om Pharmaceuticals Limited reported revenue of β‚Ή83.53 Cr. Om Pharmaceutical Industries offers products and services including Active Pharma Ingredients, Intermediates, Products Under Scale Up, and Future Products. Its focus areas include Pharmaceuticals, Chemical Intermediates, Production and Supply and Active Pharma Ingredients. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.

Company details

Om Pharmaceutical Industries specializes in manufacturing active pharmaceutical ingredients (APIs) and intermediates, drawing on over three decades of experience in the pharmaceutical sector. They operate FDA-approved facilities in Maharashtra, India, adhering to cGMP standards for quality production. The company focuses on research, development, and export to over 30 countries, ensuring reliable supply chains and compliance with international regulations.

  • Headquarters Palghar, India
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website ompharmaceutical.com
  • Legal Name Om Pharmaceuticals Limited
  • Date of Incorporation 08 Nov, 1994
  • Jurisdiction Mumbai, Maharashtra, India
Key Metrics
  • Annual Revenue
    ₹83.53 Cr

    FY 2025 · +6% YoY

  • Net Profit
    ₹7.05 Cr

    FY 2025 · 8% margin

  • EBITDA
    ₹11.60 Cr

    FY 2025 · 14% margin

Products & Services of Om Pharmaceutical Industries

Om Pharmaceutical Industries offers a comprehensive portfolio of products and services, including Active Pharma Ingredients, Intermediates, Products Under Scale Up, and Future Products.

Active Pharma Ingredients
Pharmaceutical Products

Key components for drug manufacturing used globally

Intermediates
Chemical Intermediates

Raw materials for APIs in pharmaceutical production processes

Products Under Scale Up
Development Products

Emerging items in development for future market supply

Future Products
Innovative Pharmaceuticals

Planned APIs and intermediates for upcoming releases

Board of directors of Om Pharmaceuticals Limited (Om Pharmaceutical Industries)

Om Pharmaceuticals Limited is the primary company behind Om Pharmaceutical Industries. The board of Om Pharmaceuticals Limited currently have 4 directors; the longest-serving is Vivek Gul Asrani, appointed in 2005. 5 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Vivek Gul Asrani
DIN 00114447
Director01 Apr 200521 yrs 6 moOm Pharmaceuticals Limited
Vishal Narindernath Mehra
DIN 00408740
Director20 Jul 201214 yrs 3 moOm Pharmaceuticals Limited
Chetan Doshi Mansukhlal
DIN 01306231
Director27 Dec 20196 yrs 9 moOm Pharmaceuticals Limited
Pravin Gangadhar Sonawane
DIN 10770161
Director09 Sep 20242 yrs 1 moOm Pharmaceuticals Limited

Financials of Om Pharmaceutical Industries

Figures of Om Pharmaceuticals Limited, the primary company behind Om Pharmaceutical Industries, for FY 2025. Revenue was ₹83.53 Cr (+6% year on year). Net profit was ₹7.05 Cr (8% margin). EBITDA was ₹11.60 Cr (14% margin). Revenue has grown at a compounded annual rate of +9% over three years and +12% over five years.

  • ₹83.53 CrRevenue · FY 2025 · +6% YoY
  • ₹7.05 CrNet profit · 8% margin
  • ₹11.60 CrEBITDA · 14% margin
  • ₹9.2 LakhPaid-up capital
  • 55Employees (provident fund records)
  • +9%Revenue CAGR, 3 years
  • +12%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Om Pharmaceuticals Limited are on its company page.

Premium access

Detailed financial statements for Om Pharmaceutical Industries

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Om Pharmaceutical Industries

Om Pharmaceutical Industries has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed similar companies of Om Pharmaceutical Industries

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Om Pharmaceutical Industries

Om Pharmaceutical Industries was founded in 2004.

Om Pharmaceutical Industries is headquartered in Palghar, India. It is registered at Palghar, Maharashtra, India.

The primary company behind Om Pharmaceutical Industries, Om Pharmaceuticals Limited, reported revenue of β‚Ή83.53 Cr for FY 2025, up 6% year on year.

Om Pharmaceutical Industries specializes in manufacturing active pharmaceutical ingredients (APIs) and intermediates, drawing on over three decades of experience in the pharmaceutical sector. They operate FDA-approved facilities in Maharashtra, India, adhering to cGMP standards for quality production. The company focuses on research, development, and export to over 30 countries, ensuring reliable supply chains and compliance with international regulations.

Om Pharmaceutical Industries's top competitors include Laurus Labs, Symbiotec and SeQuent.

Om Pharmaceutical Industries offers Active Pharma Ingredients, Intermediates, Products Under Scale Up, and Future Products.

Om Pharmaceutical Industries operates through Om Pharmaceuticals Limited.

The legal entities of Om Pharmaceutical Industries currently have 4 directors, including Chetan Doshi Mansukhlal, Vivek Gul Asrani, Vishal Narindernath Mehra and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available